The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Slager David Mark since 2012.
The trader's CIK number is 1477733.
At the time of the last reporting, Slager David Mark was the Officer of Oramed Pharmaceuticals Inc.. (stock ticker symbol ORMP).
Also see all insider trading activities at Oramed Pharmaceuticals Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2012 | LGDI | 46,071,905 | $3,904,254 | 0 | $0 | 0 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2017 | ORMP | 0 | $0 | 0 | $0 | 129,505 | $487,715 |
| 2014 | ORMP | 128,544 | $1,607,594 | 0 | $0 | 0 | $0 |
| 2013 | ORMP | 6,630 | $49,035 | 0 | $0 | 0 | $0 |
| 2012 | ORMP | 405,405 | $0 | 0 | $0 | 0 | $0 |
1. Legend International Holdings Inc (LGDI)
2. Oramed Pharmaceuticals Inc. (ORMP)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2012-08-07 | LGDI | Buy | 23,431,180 | .07 | 1,640,182 |
| 2012-06-25 | LGDI | Buy | 22,640,725 | .10 | 2,264,072 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2017-10-31 | ORMP | Option Ex | 16,892 | 3.77 | 63,615 |
| 2017-08-17 | ORMP | Option Ex | 112,613 | 3.77 | 424,100 |
| 2014-06-06 | ORMP | Buy | 2,252 | 4.44 | 9,998 |
| 2014-03-24 | ORMP | Buy | 27,700 | 10.15 | 281,265 |
| 2014-03-25 | ORMP | Buy | 47,300 | 10.90 | 515,570 |
| 2014-02-05 | ORMP | Buy | 24,492 | 16.32 | 399,807 |
| 2014-02-06 | ORMP | Buy | 26,800 | 14.96 | 400,954 |
| 2013-07-10 | ORMP | Buy | 6,630 | 7.40 | 49,035 |
| 2012-11-02 | ORMP | Buy | 405,405 | .00 | 0 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Slager David Mark (Officer of Oramed Pharmaceuticals Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.